Translating complex market access and reimbursement challenges into actionable commercialization strategies
Translating complex market access and reimbursement challenges into actionable commercialization strategies
Our Services
Market Access
Market Access
Market Access
Strategic alignment ensuring innovations reach the right markets and accelerate scale
Integrated market access strategy aligning regulatory, clinical, reimbursement and commercial execution
Clinical and economic evidence generation strategy
Health economics and outcomes research advisory
Reimbursement
Market Access
Market Access
Expert support to navigate coding, payment, and coverage—transforming complexity into sustainable access across care settings
Reimbursement landscape assessment
Coding application development
Payment optimization across all care settings
Payer coverage analysis and policy conversion
Health policy and agency rulemaking
Investors
Market Access
Investors
Insights and readiness helping investors evaluate risk, unlock value, and accelerate adoption
Venture Capital & Private Equity support
Investor due diligence
Reimbursement readiness for funding and investor interests
Get To Know Us
Steven Jahn, MBA, President
Voyageur Market Access was born from a simple belief: breakthrough medical technologies only matter if people can actually access them. Steven has spent more than 25 years working at the intersection of innovation, policy, and real‑world healthcare delivery — and he’s seen firsthand how even the most promising devices can stall without the right evidence, strategy, and reimbursement pathways.
His journey started inside health systems at Allina Hospitals and Clinics and the Minnesota Medical Association, where he learned how care is delivered, how providers navigate policy, and how reimbursement decisions shape what patients ultimately receive. That early experience grounded his understanding of the system from the inside out.
Steven later joined Boston Scientific, eventually serving as Vice President of Health Economics & Market Access. There, he led global reimbursement and commercialization strategies across multiple therapeutic areas — from cardiac rhythm management and electrophysiology to implantable and wearable diagnostics, cardiac independent diagnostic testing facilities, and vascular interventions. He helped teams move from early evidence planning to global adoption, translating complex policy and payment challenges into clear, actionable strategies.
Over the years, Steven became known for guiding major technology launches, supporting acquisition decisions, shaping Medicare payment mechanisms, securing CPT and ICD‑10 codes, and building evidence and coverage strategies that helped innovative devices reach the patients who needed them.
Voyageur Market Access reflects everything he’s learned along the way: that successful market access requires clarity, rigor, and a deep understanding of how clinical value, economic evidence, and policy come together. It’s a consultancy built to help innovators navigate complexity with confidence — and to ensure that life‑changing technologies don’t just get invented, but get adopted.
Contact Us
